doi: 10.1046/j.1365-2125.2003.01907.x Georges Delpre, Pinhas Stark, Yaron Niv, Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation, The Lancet, Volume 354, Issue 9180, 28 August 1999, Pages 740-741, ISSN 0140-6736,
As a result, glycemic variability during moderate activity often improves in individuals with type 2 diabetes
Many insurers cover GLP-1 medications for Type 2 diabetes
Crucially, there is no established evidence base for efficacy at low doses specifically for inflammation, and the dose-response relationship for anti-inflammatory effects is unknown
Your genetic makeup influences how quickly you metabolize these compounds and how sensitive your neurotransmitter systems are to GLP-1 signaling
The body is incredibly adaptive and will eventually settle into a new equilibrium